PharmaCyte Biotech, Inc. (NASDAQ:PMCB – Get Free Report) was down 0% during trading on Friday . The stock traded as low as $1.60 and last traded at $1.64. Approximately 8,550 shares changed hands during mid-day trading, a decline of 68% from the average daily volume of 26,475 shares. The stock had previously closed at $1.64.
PharmaCyte Biotech Stock Down 0.0 %
The firm’s 50 day simple moving average is $1.70 and its 200 day simple moving average is $1.80. The company has a market cap of $11.43 million, a price-to-earnings ratio of 2.48 and a beta of -0.21.
PharmaCyte Biotech (NASDAQ:PMCB – Get Free Report) last issued its quarterly earnings results on Friday, December 13th. The company reported ($0.29) earnings per share for the quarter.
PharmaCyte Biotech Company Profile
PharmaCyte Biotech, Inc, a biotechnology company, develops and commercializes cellular therapies for cancer in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer.
Read More
- Five stocks we like better than PharmaCyte Biotech
- Canadian Penny Stocks: Can They Make You Rich?
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- Compound Interest and Why It Matters When Investing
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- How to Invest in the FAANG Stocks
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for PharmaCyte Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaCyte Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
